PMDA Japan concludes GMP inspection of Ami Organics’ manufacturing facility in Surat

08 Jun 2024 Evaluate

Ami Organics’ manufacturing facility, Unit I situated at Sachin, Surat which is involved in manufacturing of various intermediates for Active Pharmaceuticals Ingredients, has undergone a Good Manufacturing Practices (GMP) inspection by Pharmaceutical and Medical Devices Agency, Japan (PMDA) starting June 4, 2024. The inspection has concluded successfully on June 7, 2024 without any critical/major observation. 

Ami Organics is one of the leading research and development driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical ingredients (API) for New Chemical Entities, and material for agrochemicals and fine chemicals.


AMI Organics Share Price

2118.55 21.15 (1.01%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.